← Leaderboards
Dan Landau
Dana-Farber Cancer Inst
$24,446,517
Attributed
$39,282,024
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.2M · FY2014–25$20M$15M$10M$5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,282,024 · 12
By mechanism
RM1$22,096,749 · 1
R01$10,486,243 · 5
DP2$2,542,500 · 1
R33$1,630,009 · 2
K01$981,808 · 1
UG3$833,924 · 1
Top collaborators
- Rahul Satija20 shared
- Nicolas Robine4 shared
- Omar Abdel-Wahab3 shared
- David Beck1 shared
- Peter Smibert1 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Lili Wang$5,880,767
- Matthew S Davids$2,319,476
- Shanye Yin$805,011
- Wayne A. Marasco$43,896,916
- Nathanael Schiander Gray$36,761,550
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPhenotypeTechnologyGenomicsSingle-Cell Rna SequencingMultiple OmicsEpigenetic ProcessLinkSamplingChromatinMeasurementGenetic TranscriptionMutationTranscriptomeComplexModalitySignal TransductionMapsCommunitiesCell BehaviorVariantMalignant NeoplasmsGeneticHuman Body
Grant awards (50)
Center for Integrated Cellular Analysis$10,000,000
RM1 · FY2025 · HG
Defining targetable vulnerabilities in UBA1-mutated VEXAS HSCs for clonal eradication$780,120
R01 · FY2025 · HL
Single-Cell Multi-omics to Link Clonal Mosaicism (CM) Genotypes with Chromatin, Epigenomic, Transcriptomic and Protein Phenotypes$710,791
UH3 · FY2025 · NS · contact PI
Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit$680,662
R01 · FY2025 · HL · contact PI
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy$641,130
R01 · FY2025 · CA · contact PI
Precision single-cell mapping of chromatin-associated protein activity by molecular footprinting to chart disruptions to gene regulation and dissect tumor heterogeneity in cancer$401,829
R33 · FY2025 · CA · contact PI
Center for Integrated Cellular Analysis$1,960,001
RM1 · FY2024 · HG
Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit$667,048
R01 · FY2024 · HL · contact PI
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy$609,073
R01 · FY2024 · CA · contact PI
Single-Cell Multi-omics to Link Clonal Mosaicism (CM) Genotypes with Chromatin, Epigenomic, Transcriptomic and Protein Phenotypes$405,773
UG3 · FY2024 · NS · contact PI
Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes$398,216
R33 · FY2024 · CA · contact PI
Center for Integrated Cellular Analysis - Christopher Zavala$18,335
RM1 · FY2024 · HG
Center for Integrated Cellular Analysis - Sophie Gustin$18,323
RM1 · FY2024 · HG
Center for Integrated Cellular Analysis - Olivia Taylor$18,015
RM1 · FY2024 · HG
Center for Integrated Cellular Analysis - Alisha Aristel$17,880
RM1 · FY2024 · HG
Center for Integrated Cellular Analysis$2,500,000
RM1 · FY2023 · HG
Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit$680,662
R01 · FY2023 · HL · contact PI
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy$628,307
R01 · FY2023 · CA · contact PI
Single-Cell Multi-omics to Link Clonal Mosaicism (CM) Genotypes with Chromatin, Epigenomic, Transcriptomic and Protein Phenotypes$428,151
UG3 · FY2023 · NS · contact PI
Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes$410,790
R33 · FY2023 · CA · contact PI
Center for Integrated Cellular Analysis - Salma Amin$18,335
RM1 · FY2023 · HG
Center for Integrated Cellular Analysis - Alanna Fields$18,335
RM1 · FY2023 · HG
Center for Integrated Cellular Analysis - Michelle Brose$18,335
RM1 · FY2023 · HG
Center for Integrated Cellular Analysis - Andrew Brown$18,335
RM1 · FY2023 · HG
Center for Integrated Cellular Analysis - Stephanie Figueroa Reyes$18,335
RM1 · FY2023 · HG
Center for Integrated Cellular Analysis - Lina Habba$18,335
RM1 · FY2023 · HG
Center for Integrated Cellular Analysis - Valeria A. Sanchez Estrada$18,335
RM1 · FY2023 · HG
Center for Integrated Cellular Analysis$2,500,000
RM1 · FY2022 · HG
Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit$698,037
R01 · FY2022 · HL · contact PI
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy$658,506
R01 · FY2022 · CA · contact PI
The role of DNA methylation modifiers in shaping the hematopoietic differentiation topology$493,385
R01 · FY2022 · HL · contact PI
Defining Epidrivers of CLL Evolution in Response to Targeted Therapy$456,184
R01 · FY2022 · CA · contact PI
Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes$419,174
R33 · FY2022 · CA · contact PI
Center for Integrated Cellular Analysis$2,935,850
RM1 · FY2021 · HG
The role of DNA methylation modifiers in shaping the hematopoietic differentiation topology$500,221
R01 · FY2021 · HL · contact PI
Defining Epidrivers of CLL Evolution in Response to Targeted Therapy$467,298
R01 · FY2021 · CA · contact PI
Center for Integrated Cellular Analysis$2,000,000
RM1 · FY2020 · HG
The role of DNA methylation modifiers in shaping the hematopoietic differentiation topology$506,855
R01 · FY2020 · HL · contact PI
Defining Epidrivers of CLL Evolution in Response to Targeted Therapy$480,304
R01 · FY2020 · CA · contact PI
The role of DNA methylation modifiers in shaping the hematopoietic differentiation topology$530,668
R01 · FY2019 · HL · contact PI
Defining Epidrivers of CLL Evolution in Response to Targeted Therapy$474,745
R01 · FY2019 · CA · contact PI
Shapeshifters in Cancer: Defining the Fundamental Forces of Leukemia Evolution$2,542,500
DP2 · FY2018 · CA · contact PI
Defining Epidrivers of CLL Evolution in Response to Targeted Therapy$533,038
R01 · FY2018 · CA · contact PI
The role of epigenetic heterogeneity in CLL evolution$187,920
K01 · FY2018 · ES · contact PI
The role of epigenetic heterogeneity in CLL evolution$187,920
K01 · FY2017 · ES · contact PI
The role of epigenetic heterogeneity in CLL evolution$187,920
K01 · FY2016 · ES · contact PI
The role of epigenetic heterogeneity in CLL evolution Admin supplement$43,200
K01 · FY2016 · ES · contact PI
The role of epigenetic heterogeneity in CLL evolution$123,867
K01 · FY2015 · ES · contact PI
The role of epigenetic heterogeneity in CLL evolution$63,557
K01 · FY2015 · ES · contact PI
The role of epigenetic heterogeneity in CLL evolution$187,424
K01 · FY2014 · ES · contact PI